Guru Ownership Trend
Guru Analysis for Collegium Pharmaceutical, Inc. (COLL)
Collegium Pharmaceutical, Inc. (COLL), a key player in the Healthcare sector, continues to attract institutional attention.
As of Q2 2026, a total of 6 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $58.24 M.
Top institutional holders include Renaissance Technologies (RenTech) and Chuck Royce.
Institutional sentiment is currently Slightly Bearish. This is evidenced by a $103,987.71 net outflow during the quarter.
Recent activity highlights Steven Cohen who opened a new position. Conversely, Jefferies Group reduced exposure by 45.1%.
Key Holders
Top 5 by Value
Top 5 by Conviction
Recent Activity Breakdown (Q2 2026)
Guru Consensus (Q2 2026)
FAQs for Collegium Pharmaceutical, Inc. (COLL)
Major holders include Renaissance Technologies (RenTech) ($49.47 M), Chuck Royce ($12.02 M), Cliff Asness ($5.42 M). According to the latest reported data, 6 tracked investment managers collectively hold approximately 2.06 M shares.
According to the latest 13F reporting period, sentiment appears Bearish (Net Selling). There was a net outflow of $103,987.71, with 4 managers increasing positions and 3 managers reducing holdings.
During the most recent reporting period, 1 managers trimmed their positions, while 2 fully exited COLL. The total reported sell value was $7.66 M.
Yes, 1 managers opened new positions in COLL, and 3 increased their existing holdings. The total reported buy value was $7.55 M.